Physician profile
Sinan Albear
NPI 1609371822
$15,220.60
in general payments reported to CMS, 2019-2025
16 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.00 · 2022: $344 · 2023: $597 · 2024: $174 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $14K · Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $13,808.63 |
| Food and Beverage | $1,042.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $13,871.11 | 2025 | Argos, Wavelight Refractive Suite, Rocklatan |
| New World Medical,INC. | $314.24 | 2022-2025 | Streamline, Clearpath, Via360 |
| Glaukos Corporation | $180.55 | 2023 | |
| Sight Sciences, INC. | $174.81 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Tarsus Pharmaceuticals, INC. | $144.98 | 2024-2025 | Xdemvy |
| Abbvie INC. | $131.81 | 2022-2023 | Durysta |
| Johnson & Johnson Surgical Vision, INC. | $101.66 | 2022 | |
| Biotissue Holdings INC. | $70.84 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $66.68 | 2022-2025 | Toric, Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $36.33 | 2025 | |
| Aerie Pharmaceuticals, INC. | $25.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $24.61 | 2022 | |
| Dompe US, INC. | $22.93 | 2025 | Oxervate |
| Boston Scientific Corporation | $21.87 | 2024 | Spaceoar Vue System - 10ml |
| Ocular Therapeutix, INC. | $18.92 | 2025 | Dextenza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $14.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sinan Albear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.